CoraDoc

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• Compounded tirzepatideCompounded · not FDA-approved

What they publish

CoraDoc publishes 2 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

From $149/month, described as one payment with no subscription; blocks published at $399 (about $266/mo) and $695 (about $232/mo) (as published)

Medication cost

Not publicly disclosed on the pages we captured.

Introductory offer

Not publicly disclosed on the pages we captured.

Insurance

Not publicly disclosed on the pages we captured.

HSA / FSA

Not publicly disclosed on the pages we captured.

Consultation process

Not publicly disclosed on the pages we captured.

Eligibility

Not publicly disclosed on the pages we captured.

Lab work

Not publicly disclosed on the pages we captured.

Pharmacy fulfilment

Not publicly disclosed on the pages we captured.

Shipping

Not publicly disclosed on the pages we captured.

Support services

Not publicly disclosed on the pages we captured.

Cancellation

Describes the model as a one-off payment rather than a subscription, so there is no recurring charge to cancel.

Refunds

Not publicly disclosed on the pages we captured.

What stands out

• A one-payment model means no recurring charge to cancel — which removes the cancellation friction that is a common complaint across this category.
• Publishes both block totals and effective monthly rates, making the commitment visible.
• Compounded only; no FDA-approved route published.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• Establish what the $149 covers and for how long, since the blocks work out higher per month.
• Ask which pharmacy compounds the product and whether it is a 503A or 503B facility.